Modulation of CD4+CD28null T lymphocytes by tumor necrosis factor-α blockade in patients with unstable angina

Circulation

Volumn 113, Issue 19, 2006, Pages 2272-2277

  Rizzello, Vittoria ^a,b   Liuzzo, Giovanna ^a   Brugaletta, Salvatore ^a   Rebuzzi, Antonio ^a   Biasucci, Luigi M ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Angina; Inflammation; Lymphocytes

Indexed keywords

CD28 ANTIGEN; CYTOKINE; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MECHANISM; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; CD4 LYMPHOCYTE COUNT; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

AGED; ANGINA, UNSTABLE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745003883     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.588533     Document Type: Article

References (36)

1. Fuster V, Badimon J, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and acute coronary syndromes. N Engl J Med. 1992;326:310-318.
2. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
3. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
4. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
5. Sato T. Increased subendothelial infiltration of the coronary arteries with monocytes-macrophages in patients with unstable angina. Atherosclerosis. 1987;68:191-197.
6. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophages infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
7. Van der Wal AC, Becker AE, Van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;90:775-778.
8. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Gensini GF. Transient intermittent lymphocytes activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
9. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflation in unstable angina: pathogenetic implications. J Am Coll Cardiol. 1998;32:1295-1304.
10. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. New Eng J Med. 2002;347:5-12.
11. Dinerman JL, Metha JL, Saldeen TG, Emerson S, Wallin R, Davda R, Davidson A. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol. 1990;15:1559-1563.
12. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Monaco C, Caligiuri G, Tommasi M, Rebuzzi AG, Maseri A. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27:611-616.
13. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
14. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis. 2000;9:217-222.
15. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore R, Caligiuri G, Lanza GA, Quaranta G, Monaco C, Pepys MB, Maseri A. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation. 1996;94:874-877.
16. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 1999;100:2124-2146.
17. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135-2139.
18. +CD7-CD28 T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest. 1996;97:2027-2037.
19. Liuzzo G, Goronzy JJ, Yang H Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;201:2883-2888.
20. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-α. J Immunol. 2001;167:3231-3238.
21. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation. 2004;109:2744-2748.
22. - T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int. 2004;24:351-354.
23. Knight DM, Trinh H, Le J, Siegel SA, Shealy DJ, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol. 1993;30:1443-1453.
24. Siegel SA, Shealy DJ, Nakada MT, Le J, Woulfe DS, Probert L, Kollias G, Ghrayeb J, Vilcek J, Daddona PE. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine. 1995;7:15-25.
25. St Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A, Keystone EC. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis. Arthritis Rheumatism. 2002;46:1451-1459.
26. - lymphocytes and stroke recurrence and death. Neurology. 2004;63:1446-1451.
27. Lewis DE, Merched-Sauvage M, Goronzy JJ, Weyand CM, Vallejo AN. Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. J Biol Chem. 2004;279:29130-29138.
28. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CW, Goronzy JJ. Modulation of CD28 expression with anti-tumor necrosis factor a therapy in rheumatoid arthritis. Arthritis Rheumatism. 2005;52:2996-3003.
29. null T cells in patients with acute coronary syndromes. Circulation. 2004;109:1230-1235.
30. Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Bechir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Luscher TF, Gay S, Ruschitzka F. Anti-tumor necrosis factor-α improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184-2187.
31. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol. 2005;95:3C-8C.
32. Coletta AP, Clark AL, Banariee P, Cleland JGF. Clinical trial update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur J Heart Fail. 2002;4:559-561.
33. Chung ES, Packer M, Hung Lo K, Fasanmade AA, Willerson JT, for the ATTACH Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure. Circulation 2003;107:3133-3140.
34. Altman R, Luciardi HL, Muntaner J, Del Rio F, Berman SG, Lopez R, Gonzalez C. Efficacy assessment of meloxicam, a preferential cyclo-oxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study. Circulation. 2002;106:191-195.
35. Nissen SE. High-dose statins in acute coronary syndromes: not just lipid levels. JAMA. 2004;292:1365-1367.
36. Brugaletta S, Biasucci LM, Pinelli M, Biondi-Zoccai G, Di Giannuario G, Liuzzo G, Crea F. Novel antiinflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. Heart. 2006;92:249-250.